Staking Ground in Orthopedics
Managed care is forcing suppliers and their customers into new and sometimes difficult alliances. Just a couple of years ago, few US hospitals had programs in place that reduced orthopedic implant costs through standardization and other product management strategies. If this year's Technology Futures Panel on Orthopedics sponsored by Premier Health Alliance is any indication, it seems not having such a program is the exception today.
You may also be interested in...
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.